Trials / Terminated
TerminatedNCT04249115
Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Optimization Study
Prospective, Open-Label, Multi-Center, Non-Significant Risk Study of Nano-Pulse Stimulation™ (NPS™) Technology in Healthy Adults With Seborrheic Keratosis
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 175 (actual)
- Sponsor
- Pulse Biosciences, Inc. · Industry
- Sex
- All
- Age
- 21 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Primary study objective is to evaluate the optimization of Nano-Pulse Stimulation (NPS) energy settings for lesion clearance of Seborrheic Keratosis (SKs) from off-facial areas of healthy adults.
Detailed description
* Evaluate lesion clearance rate of SKs in off-face locations post-treatment versus baseline using multiple sized treatment tips with microneedles. * Evaluate the clearance of the treated SKs using multiple energy settings at various time points initial procedure, compared baseline. * Evaluate skin effects and adverse event rate.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Nano-Pulse Stimulation (NPS) | Electrical pulses (nanosecond duration) applied directly to target SK lesions using sterile single-patient use treatment tips with microneedles. |
Timeline
- Start date
- 2019-02-05
- Primary completion
- 2020-08-13
- Completion
- 2021-04-22
- First posted
- 2020-01-30
- Last updated
- 2023-10-30
Locations
7 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04249115. Inclusion in this directory is not an endorsement.